No translate

Nguyễn Mạnh Quân; Nguyễn Quốc Thái; Nguyễn Quang Tuấn

doi:10.58354/jvc.86.2019.1154

Home

NGHIÊN CỨU LÂM SÀNG Issue: Số 86 , 2019 BỆNH MẠCH VÀNH

No translate

Published: October 16, 2026

10.58354/jvc.86.2019.1154

Abstract

No translate

Keywords

No translate

References

1. Colombo A, Drzewiecki J, Banning A, et al. (2003), Randomized study to assess the effectiveness of slow and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation, 108, 788-794.

DOI: doi.org/10.1161/01.cir.0000086926.62288.a6

2. Steg PG, Huber K, Andreotti F, et al (2011). Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J, 32, 1854-64.

DOI: doi.org/10.1093/eurheartj/ehr204

3. Levine GN, Bates ER, Blankenship JC, et al. (2011). ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 124, 574-651.

DOI: doi.org/10.1161/cir.0b013e31823ba622

4. Wenaweser P, Daemen J, Zwahlen M, et al (2008). Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol, 52, 1134-40

DOI: doi.org/10.1016/j.jacc.2008.07.006

5. Philip Urban, Alex Abizaid, et at (2013). Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy. Am Heart J, 165, 704-9.

DOI: doi.org/10.1016/j.ahj.2013.01.008

6. Urban P, Meredith IT, et al (2015). Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. N Engl J Med, 373(21):2038.

DOI: doi.org/10.1056/nejmoa1503943

7. Wijns W, Kolh P, Danchin N, et al (2010). Guidelines on myocardial revascularization. The Task Force on Myocardial revascularization of the European Society of Cardiology (ESC and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 31, 2501-55.

8. Moohammad A, Vahideh S, et al (2016). A One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention. J Tehran Heart Cent, 11(2): 62-67.

9. Robert A, Micheal J, et al (2016). Stent thrombosis and restenosis: what have we learned and where are we going? Eur Heart J, 36 (47): 3320-3331.

DOI: doi.org/10.1093/eurheartj/ehv511

Tác giả

Nguyễn Mạnh Quân: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai; Nguyễn Quốc Thái: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai; Nguyễn Quang Tuấn: Bộ môn Tim mạch - Trường Đại học Y Hà Nội;